title: The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation.
abstract: Triggering of the tissue factor (TF)-dependent coagulation pathway is considered to underlie the generation of a procoagulant state during endotoxemia. To determine the in vivo pattern of monocytic TF messenger RNA (mRNA) expression during endotoxemia, 10 healthy volunteers were injected with lipopolysaccharide (LPS, 4 ng/kg) and blood was collected before and 0.5, 1, 2, 3, 4, 6, 8, and 24 hours after LPS administration. Total blood RNA was isolated and amplified by NASBA (nucleic acid sequence-based amplification), followed by quantitation of TF mRNA by an electrochemiluminescence (ECL) assay. To compare the pattern of coagulation activation with the kinetics of monocytic TF mRNA expression, we measured plasma levels of markers of thrombin generation, thrombin-antithrombin (TAT) complexes, and prothrombin fragment 1 + 2 (F1 + 2). Baseline value (mean +/- SEM) of the number of TF mRNA molecules per monocytic cell was 0.08 +/- 0.02. A progressive and significant (P <.0001) increase in TF expression was observed after LPS injection (+0.5 hour: 0.3 +/- 0.1, +1 hour: 1.3 +/- 0.9, +2 hours: 4.1 +/- 0.9), peaking at +3 hours (10 +/- 1.9 TF mRNA molecules per monocyte). As TF mRNA levels increased, thrombin generation was augmented. Peak levels of TAT and F1 + 2 were reached later (at t +4 hours) than those of TF mRNA. TF mRNA, TAT, and F1 + 2 levels returned to baseline after 24 hours. In conclusion, we used a NASBA/ECL-based technique to quantify TF mRNA in whole blood during human endotoxemia and observed a 125-fold increase in TF mRNA levels. Our data demonstrate a pivotal role for enhanced TF gene activity in the activation of coagulation after LPS challenge. (Blood. 2000;96:554-559)
authors.affiliation: Laboratory for Experimental Internal Medicine and Department of Intensive Care, Academic Medical Center, University of Amsterdam, and Organon Teknika, Boxtel, The Netherlands.
authors.forename: R F
authors.initials: RF
authors.lastname: Franco
authors.forename: E
authors.initials: E
authors.lastname: de Jonge
authors.forename: P E
authors.initials: PE
authors.lastname: Dekkers
authors.forename: J J
authors.initials: JJ
authors.lastname: Timmerman
authors.forename: C A
authors.initials: CA
authors.lastname: Spek
authors.forename: S J
authors.initials: SJ
authors.lastname: van Deventer
authors.forename: P
authors.initials: P
authors.lastname: van Deursen
authors.forename: L
authors.initials: L
authors.lastname: van Kerkhoff
authors.forename: B
authors.initials: B
authors.lastname: van Gemen
authors.forename: H
authors.initials: H
authors.lastname: ten Cate
authors.forename: T
authors.initials: T
authors.lastname: van der Poll
authors.forename: P H
authors.initials: PH
authors.lastname: Reitsma
mesh_terms: D000328:Adult; D000990:Antithrombin III / Q000032:analysis; D001777:Blood Coagulation; D019446:Endotoxemia / Q000097:blood*; D015870:Gene Expression; D006801:Humans; D007700:Kinetics; D008070:Lipopolysaccharides / Q000494:pharmacology; D008297:Male; D010446:Peptide Fragments / Q000032:analysis; D010447:Peptide Hydrolases / Q000032:analysis; D011516:Prothrombin / Q000032:analysis; D012333:RNA, Messenger / Q000378:metabolism*; D013925:Thromboplastin / Q000235:genetics* / Q000378:metabolism
chemical_list: D008070:Lipopolysaccharides; D010446:Peptide Fragments; D012333:RNA, Messenger; C046193:antithrombin III-protease complex; C045879:prothrombin fragment 1.2; D000990:Antithrombin III; D011516:Prothrombin; D013925:Thromboplastin; D010447:Peptide Hydrolases